Skip to main content

Main navigation

  • About
    • Members
    • Our Team
    • Annual Report
    • Rutgers-NPC Health Policy & Communications Fellowship
    • NPC Summer Scholars
    • Contact Us
  • Topics
    • Health Spending
      • IRA & Medicare Drug Price Negotiation
      • 340B Drug Pricing Program
      • Understanding Health Spending
      • Low-Value Care
      • Health Spend Management
    • Value Assessment
      • Value Assessment Frameworks
      • Value Assessment Methods
      • Elements of Value
    • Alternative Payment Models
      • Value-Based Contracts
      • Regulatory Barriers & Challenges
      • Paying for Cures
      • Accountable Care Organizations
      • Bundled Payments
      • Health Care Quality Measures
      • Clinical Pathways
    • Patient-Centered Formulary & Benefit Design
      • High-Deductible Health Plans
      • Value-Based Insurance Design
      • Utilization Management & Step Therapy
      • Formulary Development
      • Patient Cost Sharing
      • Individual Treatment Effects & Personalized Access
    • Evidence for Decision Making
      • Real-World Data
      • Real-World Evidence
      • Good Practices for Evidence
    • Biopharma Innovation
      • Impact on Outcomes & Spending
  • Resources
    • Research
    • Fact Sheets
    • Policy & Evidence Briefs
    • Letters & Comments
    • E.V.I.dently Today Blog
    • Newsletters
    • Events
    • CER Daily Newsfeed®
    • Press Room
      • NPC in the News
      • NPC Press Releases
    • Videos and Graphics
    • Stakeholder Resources
      • For Employers
      • For Patient Organizations
      • Going Below The Surface
  • Get Involved
    • Become a Member
    • Submit a Research Proposal
    • Start a Career
National Pharmaceutical Council

Offscreen menu

User account menu

  • Member Resources

NPC Submits Comments to CMS Regarding the Physician Fee Schedule (PFS) Proposed Rule for CY 2026

  • Read more about NPC Submits Comments to CMS Regarding the Physician Fee Schedule (PFS) Proposed Rule for CY 2026

NPC Submits Comments to CMS Regarding IPAY 2028 Draft Guidance

  • Read more about NPC Submits Comments to CMS Regarding IPAY 2028 Draft Guidance

NPC Responds to CMS’s Proposed Rule on Policy and Technical Changes to the Medicare Advantage Program and Medicare Prescription Drug Benefit Program for CY 2026

  • Read more about NPC Responds to CMS’s Proposed Rule on Policy and Technical Changes to the Medicare Advantage Program and Medicare Prescription Drug Benefit Program for CY 2026

NPC Provides Comments to CMS on the Notice of Benefit and Payment Parameters (NBPP) for Calendar Year 2026

  • Read more about NPC Provides Comments to CMS on the Notice of Benefit and Payment Parameters (NBPP) for Calendar Year 2026

Subsequent Indications in Oncology Drugs: Pathways, Timelines, and the Inflation Reduction Act

  • Read more about Subsequent Indications in Oncology Drugs: Pathways, Timelines, and the Inflation Reduction Act

The IRA May Have Unintended Consequences on Subsequent Indications of Oncology Drugs (New Research)

  • Read more about The IRA May Have Unintended Consequences on Subsequent Indications of Oncology Drugs (New Research)

NPC Submits Comments to CMS on Proposed Rule on CY 2025 Payment Policies and More

  • Read more about NPC Submits Comments to CMS on Proposed Rule on CY 2025 Payment Policies and More

NPC Submits Comments Regarding the Medicare Hospital Outpatient Prospective Payment System

  • Read more about NPC Submits Comments Regarding the Medicare Hospital Outpatient Prospective Payment System

NPC responds to CMS's Information Collection Request on the Negotiation Data Elements and Drug Price Negotiation Process for the Initial Price Applicability Year 2027

  • Read more about NPC responds to CMS's Information Collection Request on the Negotiation Data Elements and Drug Price Negotiation Process for the Initial Price Applicability Year 2027

Statement from NPC's John O'Brien on CMS Announcement of Maximum Fair Price

  • Read more about Statement from NPC's John O'Brien on CMS Announcement of Maximum Fair Price

Pagination

  • Next page
  • Page 3
  • Next page
Subscribe to Policy & Regulatory Barriers

Let's stay in touch.

Subscribe to our newsletter.
© 2026 NPC. All rights reserved.

Footer Menu

  • Accessibility
  • Privacy Policy
  • Terms of Use
  • Contact Us

Footer Social Links Menu

  • Twitter image/svg+xml
  • Linkedin
  • Youtube